MAGE-A4 Specific TCR Lentivirus

Only %1 left
Catalog #
78935
As low as $1,150 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

MAGE-A4-Specific TCR Lentivirus are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. These viruses transduce cells with a TCR (T cell receptor) that specifically recognizes the human antigen MAGE-A4 (Melanoma-associated antigen 4) peptide 230-239 (GVYDGREHTV), and in which the TCR α chain and β chain are linked by P2A. The lentiviruses also transduce a puromycin selection marker (Figure 1).

Figure 1. (A) Schematic of the lenti-vector used to generate the MAGE-A4-Specific TCR Lentivirus and (B) diagram of the construct, showing the components of the MAGE-4-specific TCR.
TRAV and TRAC correspond to the TCR alpha chain variable and constant regions, respectively, whereas TRBV and TRBC correspond to the TCR beta chain variable and constant regions

Synonyms
Cancer/testis antigen 1.4 (CT1.4), MAGE-4 antigen, MAGE-41 antigen, MAGE-X2 antigen, Melanoma-associated antigen 4
Product Info
Storage and Usage
Citations
Supplied As
≥2 x 107 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Materials Required But Not Supplied
Name Ordering Information
Thaw Medium 2 BPS Bioscience #60184
Growth Medium 2C BPS Bioscience #79592
Assay Medium 2D BPS Bioscience #78755
CD8+ TCR Knockout NFAT-Luciferase Reporter Jurkat Cell Line BPS Bioscience #78757
T2 Cell Line ATCC #CRL-1992
MAGE-A1 Peptide (278-286) BPS Bioscience #78965
MAGE-A4 Peptide (230-239) BPS Bioscience #78966
PE anti-human α/β T Cell Receptor Antibody   BioLegend #306707 
ONE-Step™ Luciferase Assay System   BPS Bioscience #60690 
Lenti-Fuse™ Polybrene Viral Transduction Enhancer BPS Bioscience #78939
Formulation

The lentiviruses were produced in HEK293T cells in medium containing 90% DMEM + 10% FBS.  Virus particles can be packaged in custom formulations by special request, for an additional fee.

UniProt #
P43358
Background

MAGE (melanoma associated antigen) proteins are CT (cancer testis) antigens, and there are about 60 proteins in the MAGE family that can be subdivided into type I (present only on the X-chromosome, MAGE-A, B and C) and type II (MAGE D-L and necdin). Under normal conditions they are mostly found in the testis and placenta. They are found at high levels in several cancer types, such as melanoma, brain, and breast cancer, and are involved in the development of resistance to chemotherapy, cell motility and cell survival. Expression of MAGE proteins tend to correlate with a poor prognosis. They are intracellular proteins, with MAGE-A4 being found in the cytosol and nucleus, making them poor targets for strategies such as CAR-T cell therapy. MAGE proteins are degraded in the proteosome, and the peptides created can then be found on the cell membrane in combination with MHC (major histocompatibility complex) I. The presentation on the cell surface in this form makes them an attractive target for TCR (T cell receptor)-T cell therapy. Several clinical trials are ongoing, and either alone or in combination with other forms of cancer therapy the use of TCR-T cells targeting MAGE-A antigens may become a promising therapeutic avenue.

References

David O., et al., 2023 Nat Medicine 29:104-114.
De Rooji M., et al., 2023 Molecular Therapy Oncology 28:1-14.